Literature DB >> 9284247

The use of the linear-quadratic model in clinical radiation oncology can be defended on the basis of empirical evidence and theoretical argument.

D J Brenner1, D E Herbert.   

Abstract

Mesh：

Year:  1997        PMID： 9284247     DOI： 10.1118/1.598086

Source DB:  PubMed          Journal:  Med Phys        ISSN： 0094-2405            Impact factor:   4.071


× No keyword cloud information.
  4 in total

1.  On the need to compensate for edema-induced dose reductions in preplanned (131)Cs prostate brachytherapy.

Authors:  Z Jay Chen; Jun Deng; Kenneth Roberts; Ravinder Nath
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-05       Impact factor: 7.038

2.  Isoeffect calculations with the linear quadratic and its extensions: An examination of model-dependent estimates at doses relevant to hypofractionation.

Authors:  Frederick W McKenna; Salahuddin Ahmad
Journal:  J Med Phys       Date:  2011-04

3.  Applying the equivalent uniform dose formulation based on the linear-quadratic model to inhomogeneous tumor dose distributions: Caution for analyzing and reporting.

Authors:  J E McGary; W Grant; S Y Woo
Journal:  J Appl Clin Med Phys       Date:  2000       Impact factor: 2.102

Review 4.  Lessons and perspectives for applications of stochastic models in biological and cancer research.

Authors:  Alan U Sabino; Miguel Fs Vasconcelos; Misaki Yamada Sittoni; Willian W Lautenschlager; Alexandre S Queiroga; Mauro Cc Morais; Alexandre F Ramos
Journal:  Clinics (Sao Paulo)       Date:  2018-09-21       Impact factor: 2.365
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.